LYB001
From Wikipedia, the free encyclopedia
Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Virus-like particles |
| Clinical data | |
| Routes of administration | Intramuscular |
| Part ofa serieson the |
| COVID-19 pandemic |
|---|
 |
|
|
Medical response |
|
 COVID-19 portal |
LYB001is aCOVID-19 vaccinecandidate developed by Yantai Patronus Biotech Co., Ltd.[1][2][3][4]
It was found to be safe and well tolerated.[5]
References
[edit]- ^"Safety, Reactogenicity, and Immunogenicity of a Recombinant SARS-CoV-2 Vaccine LYB001 in healthy adults: a randomized, double blinded, placebo-controlled phase I trial".chictr.org.cn.Chinese Clinical Trial Registry.Retrieved15 October2021.
- ^"A Phase I Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001".ClinicalTrials.gov.18 November 2021. NCT05125926.Retrieved18 November2021.
- ^"Immunogenicity and safety of a SARS-CoV-2 Vaccine LYB001 against COVID-19 in healthy adults: a randomized, double blinded, placebo-controlled phase II trial and a single-armed, open-label expanded safety phase III trial".chictr.org.cn.Chinese Clinical Trial Registry.Retrieved15 October2021.
- ^"Phase II and III Trial of a SARS-CoV-2 Vaccine LYB001".ClinicalTrials.gov.30 November 2021. NCT05137444.Retrieved30 November2021.
- ^Tang R, Zeng Y, Zhou Y, Liang Q, Kang W, Yang Z, et al. (2 May 2024). "Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study".Expert Review of Vaccines.23(1): 498–509.doi:10.1080/14760584.2024.2337051.PMID38695310.
Scholiahas a profile forLYB001(Q110269779).
| Development | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Classes | |||||||||||
| Administration | |||||||||||
| Vaccines |
| ||||||||||
| Inventors/ researchers | |||||||||||
| Controversy | |||||||||||
| Related | |||||||||||
| |||||||||||
 | This article about COVID-19 vaccines is astub.You can help Wikipedia byexpanding it. |
 | This article aboutvaccinesorvaccinationis astub.You can help Wikipedia byexpanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=LYB001&oldid=1246977213"
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from December 2021
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- All stub articles